NASDAQ:TENX
Tenax Therapeutics, Inc.
- Stock
Last Close
3.59
16/05 20:00
Market Cap
3.01M
Beta: 2.17
Volume Today
31.65K
Avg: 3.72M
PE Ratio
−20.44
PFCF: −0.36
Apr '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 78.15% | |||||||||
cash conversion cycle | 57.75 - | ||||||||||
cash per share | 2.49K - | 287.62 88.46% | 188.92 34.32% | 109.56 42.01% | 164.40 50.05% | 17.43 89.40% | 12.95 25.70% | 5.43 58.10% | 1.44 73.40% | 39.41 2,630.59% | |
company equity multiplier | 1.13 - | 1.21 7.16% | 1.36 12.73% | 1.11 18.22% | 1.13 1.74% | 1.69 48.92% | 1.48 11.99% | 1.41 4.93% | 2.28 61.57% | 1.44 36.74% | |
days of inventory outstanding | 1.13K - | ||||||||||
days of payables outstanding | 1.16K - | ||||||||||
days of sales outstanding | 83.57 - | 366.20 338.18% | |||||||||
dividend yield | 3.87 - | ||||||||||
ebit per revenue | -57.53 - | -300.63 422.54% | |||||||||
ebt per ebit | 1.18 - | 0.95 19.21% | 0.99 3.69% | 0.96 2.56% | 0.99 2.94% | 0.98 0.73% | 1.00 1.75% | 0.99 0.61% | 1.00 0.74% | 1 0.04% | |
effective tax rate | -0.04 - | -0.02 51.55% | 0.15 961.43% | 0.04 73.00% | 0.01 71.72% | -0.00 - | -0.01 292.02% | 0.00 105.46% | |||
enterprise value multiple | 0.75 - | -6.49 969.95% | -2.32 64.35% | -1.33 42.58% | 1.52 214.45% | -0.47 131.13% | -1.37 189.21% | -0.50 63.67% | -0.18 64.14% | -0.56 214.96% | |
fixed asset turnover | 2.32 - | 1.38 40.67% | |||||||||
free cash flow per share | -401.99 - | -140.45 65.06% | -225.81 60.78% | -172.19 23.74% | -70.39 59.12% | -24.40 65.33% | -17.90 26.66% | -10.56 41.02% | -8.17 22.64% | -23.75 190.83% | |
gross profit margin | 0.55 - | 1 81.67% | |||||||||
interest coverage | -7.51 - | -301.88 3,920.51% | -1.62 99.46% | -6.07K - | -34.49K 468.61% | -2.49K 92.79% | 321.72 112.93% | ||||
inventory turnover | 0.32 - | ||||||||||
long term debt to capitalization | 0.02 - | 0.03 65.95% | 0.04 58.59% | 0.04 0.55% | |||||||
net income per ebt | 1 - | 1 0% | 0.85 15.35% | 1 18.13% | 0.99 1.17% | 1 1.19% | 1.00 0.20% | 1.01 0.59% | 1.00 0.82% | 1 0.04% | |
net profit margin | -67.68 - | -285.72 322.14% | |||||||||
operating cash flow per share | -395.71 - | -138.88 64.90% | -225.77 62.56% | -172.13 23.76% | -70.29 59.16% | -24.39 65.30% | -17.89 26.65% | -10.55 41.02% | -8.16 22.62% | -23.76 191.03% | |
operating cycle | 1.21K - | ||||||||||
operating profit margin | -57.53 - | -300.63 422.54% | |||||||||
payables turnover | 0.32 - | ||||||||||
pretax profit margin | -67.68 - | -285.72 322.14% | |||||||||
price fair value | 0.55 - | 1.52 176.51% | 3.20 109.88% | 1.56 51.35% | 0.16 89.67% | 2.32 1,339.67% | 4.17 80.01% | 5.04 20.96% | 2.19 56.60% | 0.67 69.20% | |
receivables turnover | 4.37 - | 1.00 77.18% | |||||||||
return on assets | -0.21 - | -0.19 7.76% | -1.88 875.40% | -0.89 52.51% | -0.50 43.51% | -1.32 161.21% | -1.44 8.97% | -5.46 280.07% | -3.24 40.62% | 0.66 120.35% | |
return on capital employed | -0.18 - | -0.22 18.51% | -3.07 1,317.69% | -1.04 66.26% | -0.59 43.50% | -2.23 281.17% | -2.08 6.92% | -7.39 255.74% | -7.10 3.95% | 0.95 113.41% | |
return on equity | -0.24 - | -0.23 1.15% | -2.56 999.54% | -1.00 61.16% | -0.57 42.52% | -2.23 288.99% | -2.13 4.09% | -7.71 261.33% | -7.40 4.06% | 0.95 112.87% | |
total debt to capitalization | 0.00 - | 0.00 60.29% | 0.04 - | 0.06 42.09% | 0.06 3.63% | 0.35 447.72% |
All numbers in USD (except ratios and percentages)